NBIXNeurocrine Biosciences

Each row is one issuer’s token for Neurocrine Biosciences, with the chains it is deployed on. A bold chain is one where these wallets hold a balance. Tokens are not shares: no issuer in the registry publishes a shares-per-token ratio, so a balance is counted one per share and marked where that assumption is doing work.

Tokenized versions of Neurocrine Biosciences, the issuer behind each, the chains it is deployed on, and what these wallets hold of it.

Token	Issuer	Chains	You hold
rNBIX	Reality	ARBMRPH	—
NBIXx	xStocks	SOLTONINKHYPEBNBMNTARBXLYRETH

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Type

Common stock

Sector

Healthcare › Biotechnology

Exchange

Nasdaq

Listed since

May 23, 1996

Shares outstanding

101.65M

Employees

2,500

As the market data provider names it. Where that differs from the issuers’ name for the security, both are shown so the difference is visible.